**Core Concept**
Paclitaxel is a chemotherapeutic agent used in the treatment of various cancers, including breast, ovarian, and lung cancer. Its mechanism of action is based on its ability to stabilize microtubules and interfere with cell division.

**Why the Correct Answer is Right**
Paclitaxel binds to the beta-subunit of tubulin, preventing the dissociation of tubulin dimers and thereby stabilizing microtubules. This leads to the formation of stable microtubules that are resistant to depolymerization, which is necessary for cell division. As a result, cells are unable to progress through the cell cycle, particularly during the G2/M phase, leading to cell cycle arrest and ultimately, apoptosis. The stabilization of microtubules also prevents the normal dynamic instability of microtubules, which is essential for cell movement and intracellular transport.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because paclitaxel does not work by inhibiting topoisomerase enzymes, which are involved in DNA replication and transcription.
**Option B:** This option is incorrect because paclitaxel does not work by interfering with the function of the enzyme telomerase, which is involved in maintaining telomere length.
**Option C:** This option is incorrect because paclitaxel does not work by inhibiting the enzyme tyrosine kinase, which is involved in signal transduction pathways.

**Clinical Pearl / High-Yield Fact**
Paclitaxel is often used in combination with other chemotherapeutic agents, such as carboplatin, to enhance its efficacy and reduce its toxicities. The use of paclitaxel in combination therapy has become a standard of care in the treatment of various cancers.

**Correct Answer: C. Stabilization of microtubules.**